The U.S. Food and Drug Administration (FDA) is considering ending the emergency use authorization (EUA) for Pfizer’s COVID-19 shot for children under age 5, The New York Times and The Guardian reported.
Pfizer’s shot for infants and young children has been available under EUA since June 2022, but never received full approval.
Now, the FDA may end the authorization for that age group, according to an email sent by the Centers for Disease Control and Prevention (CDC) to state and local health departments, the outlets reported. However, the shot for children 5-11 years old — also still under EUA — is expected to be fully approved this fall, the email said…
READ FULL ARTICLE HERE… (childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)






Be First to Comment